These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

581 related items for PubMed ID: 17763861

  • 1. Relationship between obstetric history and Rh(D) alloimmunization severity.
    Lobato G, Soncini CS.
    Arch Gynecol Obstet; 2008 Mar; 277(3):245-8. PubMed ID: 17763861
    [Abstract] [Full Text] [Related]

  • 2. Fetal hydrops and other variables associated with the fetal hematocrit decrease after the first intrauterine transfusion for red cell alloimmunization.
    Lobato G, Soncini CS.
    Fetal Diagn Ther; 2008 Mar; 24(4):349-52. PubMed ID: 18849608
    [Abstract] [Full Text] [Related]

  • 3. A case of severe Rh (D) alloimmunization treated by intensive plasma exchange and high-dose intravenous immunoglobulin.
    Palfi M, Hildén JO, Matthiesen L, Selbing A, Berlin G.
    Transfus Apher Sci; 2006 Oct; 35(2):131-6. PubMed ID: 17045529
    [Abstract] [Full Text] [Related]

  • 4. [Perinatal management and neurological outcome of newborns hospitalized with Rhesus hemolytic disease].
    Gobalakichenane P, Lardennois C, Galène-Gromez S, Brossard V, Marpeau L, Verspyck E, Marret S, le Réseau de périnatalité de Haute-Normandie.
    Gynecol Obstet Fertil; 2008 Oct; 36(10):984-90. PubMed ID: 18804397
    [Abstract] [Full Text] [Related]

  • 5. Experience with intrauterine transfusions for severe Rh alloimmunization in a developing country.
    Gupte SC, Lulla CP, Kulkarni SS, Korgaonkar SA, Walvekar VR, Merchant RH.
    J Matern Fetal Med; 1998 Oct; 7(6):287-91. PubMed ID: 9848694
    [Abstract] [Full Text] [Related]

  • 6. [Intrauterine transfusión in alloimmunization Rh in México 1987-2008].
    Ramírez-Robles LJ, Gómez-Partida G, Guevara-Rubio G, Velázquez-Gómez L.
    Ginecol Obstet Mex; 2010 Sep; 78(9):469-77. PubMed ID: 21961364
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Treatment of fetal anemia due to red-cell alloimmunization with intrauterine transfusions in the Netherlands, 1988-1999.
    van Kamp IL, Klumper FJ, Meerman RH, Oepkes D, Scherjon SA, Kanhai HH.
    Acta Obstet Gynecol Scand; 2004 Aug; 83(8):731-7. PubMed ID: 15255845
    [Abstract] [Full Text] [Related]

  • 9. Pediatric outcome in Rhesus hemolytic disease treated with and without intrauterine transfusion.
    De Boer IP, Zeestraten EC, Lopriore E, van Kamp IL, Kanhai HH, Walther FJ.
    Am J Obstet Gynecol; 2008 Jan; 198(1):54.e1-4. PubMed ID: 18166305
    [Abstract] [Full Text] [Related]

  • 10. The effects of serial intravascular transfusions in ascitic/hydropic RhD-alloimmunized fetuses.
    Craparo FJ, Bonati F, Gementi P, Nicolini U.
    Ultrasound Obstet Gynecol; 2005 Feb; 25(2):144-8. PubMed ID: 15660441
    [Abstract] [Full Text] [Related]

  • 11. [Analysis and perinatal outcome after intravascular transfusion].
    Monico-Ramos R, Ochoa-Flores M, Hernández-Herrera RJ, Flores-Pompa E.
    Ginecol Obstet Mex; 2011 Jun; 79(6):351-7. PubMed ID: 21966826
    [Abstract] [Full Text] [Related]

  • 12. Increased perinatal loss after intrauterine transfusion for alloimmune anaemia before 20 weeks of gestation.
    Lindenburg IT, van Kamp IL, van Zwet EW, Middeldorp JM, Klumper FJ, Oepkes D.
    BJOG; 2013 Jun; 120(7):847-52. PubMed ID: 23551577
    [Abstract] [Full Text] [Related]

  • 13. Predictive factors of perinatal mortality in transfused fetuses due to maternal alloimmunization: what really matters?
    Osanan GC, Silveira Reis ZN, Apocalypse IG, Lopes AP, Pereira AK, da Silva Ribeiro OM, Vieira Cabral AC.
    J Matern Fetal Neonatal Med; 2012 Aug; 25(8):1333-7. PubMed ID: 22046976
    [Abstract] [Full Text] [Related]

  • 14. Implementation of routine screening for Kell antibodies: does it improve perinatal survival?
    Kamphuis MM, Lindenburg I, van Kamp IL, Meerman RH, Kanhai HH, Oepkes D.
    Transfusion; 2008 May; 48(5):953-7. PubMed ID: 18248569
    [Abstract] [Full Text] [Related]

  • 15. [Blood group immunization: results of treatment of fetal anemia with intra-uterine intravascular blood transfusion in the Netherlands, 1987-1995].
    van Kamp IL, Klumper FJ, Meerman RH, Brand A, Bennebroek Gravenhorst J, Kanhai HH.
    Ned Tijdschr Geneeskd; 1999 Dec 11; 143(50):2527-31. PubMed ID: 10627756
    [Abstract] [Full Text] [Related]

  • 16. Relationship between maternal antibody type and antenatal course following intrauterine transfusion for red cell alloimmunisation.
    Walsh CA, Russell N, McAuliffe FM, Higgins S, Mahony R, Carroll S, McParland P.
    Eur J Obstet Gynecol Reprod Biol; 2013 Dec 11; 171(2):235-9. PubMed ID: 24075591
    [Abstract] [Full Text] [Related]

  • 17. Predicting Intrauterine Transfusion Interval and Perinatal Outcomes in Alloimmunized Pregnancies: Time-to-Event Survival Analysis.
    Snelgrove JW, D'Souza R, Seaward PGR, Windrim R, Kelly EN, Ryan G.
    Fetal Diagn Ther; 2019 Dec 11; 46(6):425-432. PubMed ID: 31195389
    [Abstract] [Full Text] [Related]

  • 18. The severity of immune fetal hydrops is predictive of fetal outcome after intrauterine treatment.
    van Kamp IL, Klumper FJ, Bakkum RS, Oepkes D, Meerman RH, Scherjon SA, Kanhai HH.
    Am J Obstet Gynecol; 2001 Sep 11; 185(3):668-73. PubMed ID: 11568796
    [Abstract] [Full Text] [Related]

  • 19. Management of pregnancies complicated by anti-c isoimmunization.
    Hackney DN, Knudtson EJ, Rossi KQ, Krugh D, O'Shaughnessy RW.
    Obstet Gynecol; 2004 Jan 11; 103(1):24-30. PubMed ID: 14704240
    [Abstract] [Full Text] [Related]

  • 20. Obstetric history and antibody titer in estimating severity of Kell alloimmunization in pregnancy.
    van Wamelen DJ, Klumper FJ, de Haas M, Meerman RH, van Kamp IL, Oepkes D.
    Obstet Gynecol; 2007 May 11; 109(5):1093-8. PubMed ID: 17470588
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.